课题基金 / 基金详情

PK OF LIQUID IBUPROFEN IN INFANTS, TODDLERS AND PRESCHOOLERS W/ CYSTIC FIBROSIS

PK OF LIQUID IBUPROFEN IN INFANTS, TODDLERS AND PRESCHOOLERS W/ CYSTIC FIBROSIS
液体布洛芬在患有囊性纤维化的婴儿、幼儿和学龄前儿童中的药代动力学
批准号:
6280817
负责人:
GERD CROPP
金额:
$2.39万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

GERD CROPP的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The inflammatory airway injury in Cystic Fibrosis can be lessened by oral ibuprofen therapy provided airway injury is in its early stages. The most important time to offer this therapy is, therefore, before or during the early phases of airway inflammation and injury in young children with CF who cannot take tablets of ibuprofen; liquid formulations are needed to treat them. The pharmacokinetics of liquid ibuprofen is not known in children with CF<6 years of age, and it may differ in infants, toddlers and preschool children from older children and adults with CF. The absorption of liquid ibuprofen may also differ from tablet formulations of ibuprofen. This study will describe the pharmacokinetics of liquid ibuprofen in infants, toddlers and preschool children. It is anticipated that liquid ibuprofen is absorbed faster, more uniformly and more completely than tablet formulation. As a result, plasma concentrations will rise faster, reach a peak sooner and then decay in a more predictable fashion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PK OF LIQUID IBUPROFEN IN INFANTS, TODDLERS AND PRESCHOOLERS W/ CYSTIC FIBROSIS
PHARMACOKINETICS OF LIQUID IBUPROFEN IN CHILDREN WITH CYSTIC FIBROSIS
PHARMACOKINETICS OF LIQUID IBUPROFEN IN CHILDREN WITH CYSTIC FIBROSIS
PK OF LIQUID IBUPROFEN IN INFANTS, TODDLERS AND PRESCHOOLERS W/ CYSTIC FIBROSIS
海外基金